Click on a filter below to refine your search. Remove a filter to broaden your search.
It is unclear whether the S-Elixhauser comorbidity score offers an advantage over other similar measures.
Declines in life expectancy were seen for males and females and for all race and Hispanic-origin groups.
The move comes as the stockpile of test kits is shrinking and fewer Americans are testing for COVID-19.
Older adults in the most versus the least resilient group had increases in mean gait speed and walking distance after 16 weeks.
Increased odds of not making medication-related errors were found for nurses who had attended training within past two years versus a longer period.
Higher pain, fatigue and depressive symptoms were linked to increased odds of being in a high disability trajectory, irrespective of inflammation.
Enrollees with Alzheimer’s disease and related dementias had increased adjusted mortality, especially for Asian, Black and Hispanic populations.
No impact on progression to severe disease was seen for high-risk patients with mild-to-moderate disease receiving ivermectin during early illness.
The overall rate of colonoscopy completion was 85% in the Hispanic population; the reasons for cancellation and no-show included cost.
Mortality due to COVID-19 had the biggest effect on decline in life expectancy for both men and women, all races examined.